Name of company
Place of incorporation
Date of incorporation
Percentage of ownership by the Group
Principal activities
BeyondSpring Pharmaceuticals Inc. (“BeyondSpring US”)
Delaware, U.S.
June 18, 2013
100%
Clinical trial activities
BeyondSpring Australia Pty Ltd
Australia
June 29, 2026
Wanchun Biotechnology Limited (“BVI Biotech”)
BVI
April 1, 2015
Holding company
A tabular disclosure of ownership percentage of subsidiaries of the company.
No definition available.